Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: Insider Sales Continue 90-Day Trend at Repligen

03/18/2021 | 08:50pm EDT


ę MT Newswires 2021
All news about REPLIGEN CORPORATION
05/05REPLIGENá : HC Wainwright Adjusts Repligen's Price Target to $240 From $225, Mai..
MT
05/04REPLIGENá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04REPLIGENá : Posts Rise in Q1 Adjusted Profit, Revenue; Amends 2021 Forecasts
MT
05/04REPLIGENá : Reported revenue was $142.8 million for the quarter, representing ye..
PU
05/04REPLIGEN CORPá : Results of Operations and Financial Condition, Financial Statem..
AQ
05/04REPLIGEN : Q1 Earnings Snapshot
AQ
05/04REPLIGENá : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $142.8M,..
MT
05/04REPLIGENá : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 EPS $0.68, vs...
MT
05/04Repligen Reports First Quarter 2021 Financial Resultsáand Updates Full Year 2..
GL
04/20Repligen to Report First Quarter 2021 Financial Results
GL
More news
Financials (USD)
Sales 2021 585 M - -
Net income 2021 97,5 M - -
Net cash 2021 596 M - -
P/E ratio 2021 110x
Yield 2021 -
Capitalization 10 311 M 10 311 M -
EV / Sales 2021 16,6x
EV / Sales 2022 13,9x
Nbr of Employees -
Free-Float 91,7%
Chart REPLIGEN CORPORATION
Duration : Period :
Repligen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REPLIGEN CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 240,25 $
Last Close Price 187,80 $
Spread / Highest target 33,7%
Spread / Average Target 27,9%
Spread / Lowest Target 6,50%
EPS Revisions
Managers and Directors
NameTitle
Tony J. Hunt President, Chief Executive Officer & Director
Jon K. Snodgres Chief Financial Officer
Karen T. Dawes Chairman
Ralf Kuriyel Senior Vice President-Research & Development
James R. Bylund Senior Vice President-Global Operations & IT
Sector and Competitors
1st jan.Capitalization (M$)
REPLIGEN CORPORATION-2.00%10 311
ABBOTT LABORATORIES8.64%211 353
MEDTRONIC PLC8.16%170 801
BECTON, DICKINSON AND COMPANY-4.33%69 619
ALIGN TECHNOLOGY, INC.11.97%47 351
HOYA CORPORATION-7.88%44 672